Christopher Cabell
CIK 1814928 · President & Head of R&D · last filed 2026-02-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.13M
Companies
4
Total Filings
12
Lifetime Open-Market Net
-$884.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IKT | President & Head of R&D | 676,564 | $1.67 | $1.13M | $0 | 4 | 2026-02-24 |
| Zura Bio Ltd (ZURAW) Delisted | CMO & Head of R&D | 162,060 | $1.08 | $175.0K | $0 | 1 | 2023-05-22 |
| PULM | Director | — | $1.40 | — | $0 | 4 | 2023-01-30 |
| ARENA PHARMACEUTICALS INC (ARNA) Delisted | EVP, Head of R&D, and CMO | 1,401 | $99.99 | $140.1K | -$884.0K | 3 | 2020-11-30 |
Recent Filings · Page 2 of 2
12 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-06-25 | PULM | Grant (A) | — | $0 | EDGAR |
| 2020-06-16 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–12 of 12
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.